395-22750-96009
3 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 606 / IL
- Registered
- 2021-10-18
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2021-01-07
Dose 2 — Pfizer-BioNTech
-
2021-10-17
Dose 3 — Pfizer-BioNTech
-
2021-10-18
Registered in v-safe
-
2021-10-18
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-19
- 2021-10-20
- 2021-10-21
-
2021-10-24
Survey response — day 7, dose 3MedDRA: Cough, Rhinorrhoea, Throat irritation — Feeling: FairFree text: Cough, runny nose, scratchy throatMedDRA releases: 2024-11 · check-in free text available
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2021-11-21
- 2022-01-16
- 2022-04-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | No |
| 2 | 2021-01-07 | Pfizer-BioNTech | No |
| 3 | 2021-10-17 | Pfizer-BioNTech | No |
Free text
Release 10 — day 7, dose 3
Systemic reaction (other): Cough, runny nose, scratchy throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Cough | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Throat irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release